Investors

Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital ... More >>

Stock Quote

CSII (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$24.40
Change (%) Stock is Up 0.77 (3.26%)
Volume508,138
Data as of 10/01/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

More >>
09/17/14
Cardiovascular Systems, Inc.’s Board Chair to Retire
After 11 Years of Service—Seven as Chair—Glen D. Nelson, M.D., Will Not Seek Re-election; Director Scott R. Ward Named Chairman ST. PAUL, Minn.--(BUSINESS WIRE)--Sep. 17, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today announced that its chairman of the board, Glen D. Nelson, M.D., 77, plans to retire and will not stand for re-election at the company’s 2014 annual meeting of shareholders on November 12, 2014—when his term ends. In appr... 
09/15/14
Cardiovascular Systems Releases New Peripheral Data at 2014 TCT Conference
TRUTH Study Demonstrates Orbital Atherectomy’s Effectiveness at Reducing and Modifying Calcified Lesions with Low Procedural Complications ST. PAUL, Minn.--(BUSINESS WIRE)--Sep. 15, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), unveiled new data about the treatment of arterial calcification at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington D.C. Arterial calcium is a common occurrence for the millio... 
08/06/14
Cardiovascular Systems Reports Fiscal 2014 Fourth-Quarter and Full-Year Financial Results
Conference Call Scheduled for Today, August 6, 2014, at 3:45 PM CT (4:45 PM ET) Key Financial and Operating Highlights for the Fourth Quarter: Revenues of $39.6 million rose 37 percent from 2013 fourth quarter Market expanding Diamondback 360® Coronary and Diamondback 360® 60cm Peripheral Orbital Atherectomy Systems (OAS) contribute to strong top-line growth Company enrolls first pa... 
07/23/14
Cardiovascular Systems to Webcast Fiscal 2014 Fourth-Quarter Earnings Conference Call Wednesday, August 6
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) ST. PAUL, Minn.--(BUSINESS WIRE)--Jul. 23, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 fourth-quarter conference call on Wednesday, August 6, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal fourth quarter end... 

Upcoming Events

More >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.